Peachaphol Chongvoranond et al. 2025. Sodium-Glucose Cotransporter-2 inhibitor (SGLT2i) Prescription Rates Amongst Diabetologists for Type 2 Diabetes Patients with Albuminuric Diabetic Kidney Disease:: A Real-World Study at a Diabetes Center in Bangkok. Journal of the ASEAN Federation of Endocrine Societies. 40, 2 (Nov. 2025), 69–77. DOI:https://doi.org/10.15605/jafes.040.02.22.